跳至主要内容
临床试验/NCT04838093
NCT04838093已完成不适用

COVID-19 Testing in Patients With Vascular Disorders - a Prospective Cohort Study at a Tertiary Care Hospital

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 2,243 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,243
试验地点
1
主要终点
prevalence of SARS-CoV-2 infection

研究概览

简要总结

Background: To investigate the prevalence of SARS-CoV-2 infection in hospitalized patients with vascular disorders after implementing institutional and governmental safety measures.

Materials and Methods: Vascular patients (VPs) admitted to our tertiary care hospital were routinely tested for SARS-CoV-2 infection on a two days basis between March and December, 2020. The prevalence of SARS-CoV-2 was compared between VPs and two independent Austrian populations (April and November 2020) tested by the Austrian Ministry of Science. The results were also compared to a cohort of health care personnel (HCP) working in close proximity to the study patients, tested weekly, between March and December, 2020. RT-PCR and antigen test were used to detect SARS-CoV-2.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • All inpatient admissions

排除标准

  • Outpatient admissions

结局指标

主要结局

prevalence of SARS-CoV-2 infection

时间窗: March 16 to December 07, 2020

The primary endpoint of the present study was to determine the prevalence of SARS-CoV-2 infection in patients with vascular disease after the implementation of institutional and governmental safety measures and compared it to SARS-CoV-2 infections among the general population in Austria.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohammad M. Kasiri

Resident doctor in general surgery

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验

COVID-19 Testing in Patients With Vascular Disorders | 临床试验